HEXALYSE

This brand name is authorized in Lithuania

Active ingredients

The drug HEXALYSE contains a combination of these active pharmaceutical ingredients (APIs):

1 Biclotymol
UNII W4K0AE8XW9 - BICLOTYMOL
Read about Biclotymol
2 Lysozyme
UNII 968JKA7T33 - LYSOZYME

Lysozyme is a naturally occurring enzyme found in bodily secretions such as tears, saliva, and milk. It functions as an antimicrobial agent by cleaving the peptidoglycan component of bacterial cell walls, which leads to cell death.

Read about Lysozyme
3 Enoxolone
UNII P540XA09DR - ENOXOLONE

Enoxolone is a pentacyclic triterpenoid aglycone metabolite of glycyrrhizin, which is a product of the plant Glycyrrhiza glabra (licorice), with potential expectorant, and gastrokinetic activities. After administration, enoxolone inhibits the metabolism of prostaglandins by both 15-hydroxyprostaglandin dehydrogenase [NAD] and prostaglandin reductase 2.

Read about Enoxolone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R02AA20 Various R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1006982

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.